GF Fund Management
VERA icon

GF Fund Management’s Vera Therapeutics VERA Stock Holding History

GF Fund Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$60.7K Buy
1,880
+368
+24% +$12.9K ﹤0.01% 373
2026
Q2 		$64.9K Buy
1,512
+76
+5% +$2.83K ﹤0.01% 367
2026
Q1 		$57.8K Buy
1,436
+180
+14% +$7.76K ﹤0.01% 383
2025
Q4 		$63.6K Sell
1,256
-117
-9% -$4.16K ﹤0.01% 385
2025
Q3 		$39.9K Sell
1,373
-248
-15% -$5.74K ﹤0.01% 417
2025
Q2 		$38.2K Hold
1,621
– – ﹤0.01% 442
2025
Q1 		$38.9K Buy
1,621
+291
+22% +$9.35K ﹤0.01% 443
2024
Q4 		$56.2K Buy
+1,330
New +$58.9K ﹤0.01% 380

Other funds holding VERA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

GF Fund Management's VERA Position: Q3 2026 in Review

GF Fund Management increased its Vera Therapeutics (VERA) stake by 24% in Q3 2026, buying an estimated $12.9K and bringing the position to 1,880 shares worth $60.7K. The position accounts for ﹤0.01% of the portfolio, ranked #373.

GF Fund Management first reported a position in VERA in Q4 2024 and has held it in 8 quarters since. The position peaked at $64.9K in Q2 2026. 91 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • GF Fund Management held 1,880 shares of Vera Therapeutics worth $60.7K as of Q3 2026.
  • GF Fund Management bought 368 Vera Therapeutics shares in Q3 2026, an estimated $12.9K.
  • Vera Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #373 holding.
  • GF Fund Management first reported a position in Vera Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • GF Fund Management's Vera Therapeutics position peaked at $64.9K in Q2 2026.
  • 91 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.